Mitochondria as the hub for drug tolerance during fungal aging and starvation
Antimicrobial Agents and Chemotherapy · 18.11.2026
DOI: 10.1128/aac.00937-26 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antimicrobial Agents and Chemotherapy, online erschienen am 18.11.2026. Verfasst von Somanon Bhattacharya und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Stony Brook University, Stony Brook, New York, USA. Die Arbeit nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health, Biomedical Laboratory Research and Development, VA Office of Research and Development.
Abstract (Originalsprache)
Opportunistic fungal pathogens, including Candida , Aspergillus , and Cryptococcus species, employ metabolic and organellar adaptations to survive host stresses and antifungal treatments. Cryptococcus neoformans thrives in a nutrient-limiting environment and undergoes prolonged replicative stress during chronic infection. Nutrient limitation is modeled as calorie restriction (CR), while replicative stress is manifested through replicative aging (RA). C. neoformans adapts to these stresses and undergoes many physiological changes. These changes include increased azole tolerance and higher drug efflux pump activities during CR and RA, which correlate with altered mitochondrial structures and functions. Mitochondrial pathways behave differently under RA and CR stress. For example, mitochondrial mass is significantly higher in aging cells, while it is significantly lower in CR-adapted cells. The role of mitochondria in antifungal tolerance in both RA and CR cells remains poorly understood. Multiple mitochondrial pathways contribute to antifungal tolerance. These include regulation of respiration, mitochondrial genome and protein functions, and calcium and iron homeostasis. Several inhibitors have been identified to target these mitochondrial pathways. The effects of these inhibitors on lowering antifungal tolerance in CR and RA-adapted cells need to be studied. This will aid in next-generation drug designing to combat the growing frequency of antifungal tolerance, especially in C. neoformans .
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Medicine, Stony Brook University, Stony Brook, New York, USA.
- Department of Microbiology and Immunology, Renaissance School of Medicine, Stony Brook University, Stony Brook, New York, USA.
- Veterans Administration Medical Center, Northport, New York, USA.
ORCID-Profile: Somanon Bhattacharya, Natalia K Oliveira, Kyungyoon Yoo, Bettina C Fries
Förderung
- National Institutes of Health
- Biomedical Laboratory Research and Development, VA Office of Research and Development
Zitieren
APA
Bhattacharya, S., Oliveira, N. K., Yoo, K., & Fries, B. C. (2026). Mitochondria as the hub for drug tolerance during fungal aging and starvation. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00937-26
Vancouver
Bhattacharya S, Oliveira NK, Yoo K, Fries BC. Mitochondria as the hub for drug tolerance during fungal aging and starvation. Antimicrobial Agents and Chemotherapy. 2026. doi:10.1128/aac.00937-26
BibTeX
@article{Bhattacharya2026,
author = {Bhattacharya, Somanon and Oliveira, Natalia K and Yoo, Kyungyoon and Fries, Bettina C},
title = {Mitochondria as the hub for drug tolerance during fungal aging and starvation},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2026},
doi = {10.1128/aac.00937-26}
}
EUVIMED